title: [Case report: cutaneous tuberculosis and tuberculous osteomyelitis].
abstract: In this report, a 27 years old male patient diagnosed to have skin and bone tuberculosis (TB) has been presented. The patient admitted to the hospital with the complaints of fever, weight loss and night sweats. Patient's history revealed that following a trauma a skin lesion in the right ankle was developed and this was followed by the development of many lesions in different parts of the body. The lesions persisted despite the use of various antibiotics since a year. It has been recorded that his father has already been receiving anti-tuberculosis treatment. Osteomyelitis was detected in the distal part of right tibia by computerized tomography, and Mycobacterium tuberculosis was isolated from the specimens of skin lesion. The patient was immunocompetent, and there was no pulmonary involvement. Isoniazid (INAH), rifampin (RIF), ethambutol and morphozinamid therapy has been started and completed to 12 months with INAH and RIF. In the post-treatment follow-up of patient for one year, no relapse was detected. As a result, tuberculosis should be considered in patients with persistent skin lesions especially in endemic countries.
authors.affiliation: Ankara Numune Egitim ve Araştirma Hastanesi Birinci infeksiyon Hastaliklari ve Klinik Mikrobiyoloji Klinigi, Ankara.
authors.forename: Aysel Kocagul
authors.initials: AK
authors.lastname: Celikbaş
authors.forename: Ayfegül
authors.initials: A
authors.lastname: Ulu
authors.forename: Onder
authors.initials: O
authors.lastname: Ergönül
authors.forename: Sebnem
authors.initials: S
authors.lastname: Eren
authors.forename: Nurcan
authors.initials: N
authors.lastname: Baykam
authors.forename: Başak
authors.initials: B
authors.lastname: Dokuzoguz
mesh_terms: D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007121:Immunocompetence; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D010019:Osteomyelitis / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D011719:Pyrazines / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D013977:Tibia; D014057:Tomography, X-Ray Computed; D014382:Tuberculosis, Cutaneous / Q000175:diagnosis* / Q000188:drug therapy; D014394:Tuberculosis, Osteoarticular / Q000175:diagnosis* / Q000188:drug therapy
chemical_list: D000995:Antitubercular Agents; D011719:Pyrazines; C038993:morphazinamide; D007538:Isoniazid; D012293:Rifampin